FDA Inspection 930212 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 1076406

The FDA completed an inspection of Octapharma Plasma, Inc. on May 15, 2015 in North Charleston, SC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 15, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
North Charleston, SC (United States)

Citations

IDCFRDescription
16021 CFR 606.160(a)(1)Person performing, test results, interpretation
923421 CFR 630.40(c)Notification w/in 8 weeks